Return to content in this issue

Efficacy and safety of nemolizumab for adult atopic dermatitis treatment: A meta-analysis of randomized clinical trials

Xuemin X¹*, Lihang L¹*, Changhua Z¹, Xiaofang Y¹, Yongshan N¹, Zhipeng L¹, Chong J², Yue H<sup>1

1</sup>Department of Dermatology, the Union Hospital, Fujian Medical University, Fuzhou, P.R. China
²College of Materials Science and Engineering, Nanjing Forestry University, Nanjing, P.R. China
*These authors contributed to the work equally.

J Investig Allergol Clin Immunol 2021; Vol. 31(2)
doi: 10.18176/jiaci.0672

• Abstract
• Supplemental Materials

Key words: Nemolizumab, Meta-analysis, Atopic dermatitis, Efficacy, Safety

	Title	Type	Size
	doi10.18176_jiaci.0672_material-suppl_figures.pdf	pdf	703.10 Kb
	doi10.18176_jiaci.0672_material-suppl_tables.pdf	pdf	279.32 Kb